乳腺癌患者骨病灶SPECT/CT融合显像的临床价值

樊孝廉; 鲁胜男; 古炎发; 张爱芳; 樊孝廉; 鲁胜男; 古炎发; 张爱芳

doi:10.3760/cma.j.issn.1673-4114.2013.04.008

[1]

Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin, 2007, 57(1): 43-66. doi: 10.3322/canjclin.57.1.43

[2]

周涛, 陈丽芬. 30岁以下乳腺癌临床病理特征及分子生物学特点分析.国际肿瘤学杂志, 2006, 33(11): 874-877. doi: 10.3760/cma.j.issn.1673-422X.2006.11.024

[3]

汤志谋, 许海富, 李明智. SPECT核素骨显像联合MRI增强成像鉴别诊断骨转移瘤100例临床观察.实用癌症杂志, 2009, 24(5): 498-500. doi: 10.3969/j.issn.1001-5930.2009.05.019

[4]

韩鹏慧, 张书旭, 葛永兵, 等. SPECT/螺旋CT融合显像鉴别诊断颅骨良恶性病变的临床价值.中国临床医学影像杂志, 2012, 23(7): 484-487. doi: 10.3969/j.issn.1008-1062.2012.07.008

[5]

李少林, 王荣福.核医学. 7版.北京:人民卫生出版社, 2008: 153.

[6]

Even-Sapir E. Imaging of malignant bone involvement by morphologic, scintigraphic and hybrid modalities. J Nucl Med, 2005, 46(8): 1356-1367.

[7]

Horger M, Bares R. The role of single photon emission computed tomography/computed tomography in benign and malignant bone disease. Semin Nucl Med, 2006, 36(4): 286-294.

[8]

Sharma P, Singh H, Kumar R, et al. Bone scintigraphy in breast cancer: added value of hybrid SPECT-CT and its impact on patient management. Nucl Med Commun, 2012, 33(2): 139-147.